More than 215,000 scientists worldwide across pharma, biotech, and academia
-
Pfizer
One of the world's largest pharmaceutical companies developing cutting-edge drugs in immunology, oncology, cardiology, and more.
-
Regeneron
A leading biotechnology company using the power of science to bring new medicines to patients in need.
-
Zoetis
Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways, delivering medicines, vaccines, and diagnostic products.
-
Ginkgo
Ginkgo Bioworks is designing custom organisms for customers across multiple markets, learning from nature to replace technology with biology.
-
Mammoth Biosciences
Mammoth Biosciences provides a CRISPR-based platform for disease detection across healthcare, agriculture, and other industries
-
Daiichi Sankyo Inc
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan.
-
Eisai
Eisai is a human health care (hhc) company seeking innovative solutions in disease prevention, treatment and care for the health and well-being of people worldwide.
-
BEAM Therapeutics
Beam is pioneering the use of base editing — a potential new class of precision genetic medicines — with a vision of providing life-long cures to patients suffering from serious diseases.
-
BP Biosciences
BP’s Biosciences Center conducts innovative research, supports strategic investments and manages academic partnerships designed to accelerate the global transition to a low-carbon future.
-
Arsenal Biosciences
ArsenalBio was founded to discover, develop and commercialize curative immune cell therapies.
-
Rubius
Rubius Therapeutics is realizing the power of red by creating red blood cells and transforming them into cellular medicines.
Case Study
-
Kite Pharma
Kite, a Gilead company, is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer.
-
Zymergen
Unlocking the power of biology to make strain optimization as reliable and predictable as other engineering processes.
Case Study
-
Spotlight Therapeutics
We are creating next-generation programmable nucleases that can selectively edit specific cell populations directly in the body.
-
Kyverna Therapeutics
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
-
Pairwise
Pairwise is bringing together leaders in agriculture and technology to harness the potential of genome editing to address consumers’ and farmers’ needs.
-
Editas
A leading genome editing company dedicated to treating patients with genetically defined diseases.
-
Insitro
insitro will integrate cutting-edge machine learning techniques with the innovations that have occurred in life sciences that enable the creation of the large, high-quality data sets.
-
Bolt Threads
Bolt Threads is bioengineering the next generation of fabrics and garments with their Microsilk and Mylo technologies.
-
Denali Therapeutics
Denali Therapeutics is dedicated to defeating neurodegenerative diseases through rigorous therapeutic discovery and development.
-
Sorrento
Sorrento Therapeutics is a clinical stage, antibody-centric biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possible curable diseases.
-
Lyell Immunopharma
Lyell Immunopharma Inc. is a cellular therapy company dedicated to mastering immune cell functionality.
-
Sana Biotechnology
Sana is creating engineered cells to repair and control genes in cells or replace missing or damaged cells to solve the underlying causes of disease.
-
Synlogic
Synlogic is working at the cross section of biology and engineering, advancing a new class of medicines for patients.
Case Study
-
Adicet Bio
Universal, off-the-shelf immune cell therapy for treatment of cancer and other diseases
Case Study
-
Ligand Pharmaceuticals
Ligand has one of the largest and most diverse portfolios in the pharmaceutical industry. Currently approved portfolio drugs include those that treat cancer, osteoporosis, and fungal infections.
-
Arcturus Therapeutics
An industry leader in the application of RNA technologies for the treatment of disease and improved quality of life.
Case Study
-
Caribou Biosciences
Advancing new applications for CRISPR-Cas gene editing to help bring the promise this technology holds for patients and consumers to reality.
-
New England Biolabs
Recombinant and native enzyme reagents for life science research. Provides solutions supporting genome editing, synthetic biology and next-generation sequencing.
-
Synthego
Synthego is the genome engineering innovation company.
-
Agenus
Using the power of the immune system to develop a broad range of innovative therapeutic antibody and vaccine candidates against cancer.
Case Study
-
Dragonfly Therapeutics
Developing novel first-in-class therapeutics targeted at Natural Killer cells and other cells of the innate immune system.
-
eGenesis
Making xenotransplantation a routine medical procedure for the delivery of safe & effective human transplantable cells, tissues & organs.
-
IGM Biosciences
IGM is pioneering the development of the IgM class of antibodies as therapeutic treatments for human disease.
-
Invaio Sciences
Invaio Sciences is a transformative early-stage startup developing a platform to control the fitness and behavior of pests and target insects in a targeted, sustainable, and natural way.
-
Kymera Therapeutics
Kymera Therapeutics is pioneering a new therapeutic modality and platform to transform drug discovery and deliver breakthrough medicines for previously untreatable diseases.
-
Tenaya Therapeutics
Tenaya is addressing heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle.
-
TScan Therapeutics
TScan is harnessing novel T cell systems to extend the promise of immunotherapy.
-
Ambys Medicines
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies for people with advanced liver disease.
-
Arcus Biosciences
Arcus is utilizing its small molecule discovery and development capabilities to create innovative cancer immunotherapies.
-
Bio-Techne
Bio-Techne (formerly Techne Corp.), NASDAQ: TECH, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities.
-
Bioverativ
Bioverativ Inc. is an American multinational biotechnology that specializes in the discovery, development, and delivery of therapies for the treatment of haemophilia.
-
Modern Meadow
Modern Meadow is pioneering a new age of biologically advanced materials.
-
Surrozen
Surrozen is discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway.
-
Adimab
A premier human antibody discovery and optimization platform defined by speed, diversity, and quality.
-
Antheia
Providing a stable and cost-competitive supply of plant-based medicines and to transform the discovery, manufacture, and distribution of medicines.
-
Atreca
Atreca focuses on the immune responses of patients to discover and develop novel immunotherapies.
-
Cedilla Therapeutics
Cedilla is harnessing intrinsic protein stability mechanisms to broaden the reach of small molecule therapeutics to work on diseases caused by protein dysregulation.
-
Cue Biopharma
Cue Biopharma is an immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system.
-
CytomX
CytomX is a clinical-stage biopharmaceutical company – intent on revolutionizing the way we treat cancer.
-
Harpoon Therapeutics
Leveraging a platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other diseases
-
Hibercell
HiberCell is developing first-in-class therapeutics that target dormant disseminated tumor cells from solid and liquid cancers to the prevent or delay the recurrence of cancer.
-
Lung Biotechnology
Lung Biotechnology's mission is to simplify and democratize the treatment of lung disease, using biotechnology to design therapies for PAH and other fatal lung diseases.
-
Recursion Pharmaceuticals
Discovering transformative new treatments by leveraging the speed of automation with the intelligence of computers.
-
Senti Biosciences
Leveraging expertise in cell engineering and biological programming to build the future of gene and cell based therapies.
-
Translate Bio
Translate Bio is an mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.
-
uniQure
Delivering on the promise of gene therapy, single treatments with potentially curative results.
-
Xencor
Expanding the therapeutic boundaries of monoclonal antibody drugs with its XmAb antibody engineering platform.
-
Arbor Biotechnologies
We have built a next-generation biodiscovery platform to uncover novel CRISPR enzymes and systems that can power transformative applications across a range of industries.
-
Arch Oncology
At Arch Oncology, we are aiming high to discover and develop new antibody therapeutics to treat patients living with cancer.
-
Arvinas
At Arvinas, we’re leading the creation of an entirely new way to treat disease through therapies that target and degrade disease-related proteins.
-
Cogen Therapeutics
Cogen Therapeutics develops immune modulation therapeutics that control the immune system, targeting the specific drivers of disease.
-
Sound Agriculture
Sound Agriculture, formerly known as Asilomar Bio, is developing technologies to help growers sustainably increase productivity by enhancing crop nutrient and water use.
-
Synbal
Synbal, Inc. is using its proprietary next-generation gene-editing platform, Active Genetics, to develop safer, non-viral, cell-based gene therapy candidates.
-
Alector
Our mission is to eliminate neurodegeneration through immuno-neurology. This is a therapeutic approach that harnesses the body's own immune system to combat these devastating diseases.
-
ABL Bio
ABL Bio is one of the world's leading biotech research companies focusing on the development of therapeutic drugs for immuno-oncology & neurodegenerative diseases.
-
Carisma Therapeutics
Carisma Therapeutics is pioneering CAR macrophage immunotherapy to target solid tumors.
-
Cygnal Therapeutics
Cygnal Therapeutics is developing drugs to manipulate exoneural biology for the treatment of cancer, immunological diseases, and regenerative processes.
-
Eligo Bioscience
Developing a new class of targeted biotherapeutic agents to selectively intervene on the microbiome.
-
Inari
Developing and delivering innovative therapies that harness the human gut microbiome.
-
Incyte
Investigating the immune-suppressive tumor microenvironment through both small and large molecule approaches that target diverse mechanisms.
-
Maverick Therapeutics
Redirected T cell therapeutics designed to deliver potent activity with increased tumor specificity and reduced toxicity.
-
Obsidian Therapeutics
Building cell therapies with pharmacologic operating systems to provide treating physicians with precise and dynamic control of engineered cells in patients.
-
Orum
Developing next-generation therapeutic antibodies to directly target cytosolic proteins associated with many human diseases that have been previously considered untreatable.
-
Pandion Therapeutics
Shifting the paradigm from systemic immunosuppression to localized immunomodulation with the next generation of targeted therapeutics.
-
Verseau
Transforming immunotherapy.
-
Voyager Therapeutics
Developing life-changing gene therapies with a focus on severe neurological diseases that lack safe and effective treatment options.
-
Amicus Therapeutics
Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases.
-
Amunix
Amunix is leveraging our expertise in precision protein engineering to enable the promise of T cell engagers in solid tumors.
-
Biodesy
Biodesy is developing the first products and systems to rapidly and inexpensively measure structural changes of biological molecules in real time.
-
CERo Therapeutics
CERo Therapeutics, Inc. is a new cellular immunotherapy company. We have created a hybrid platform that integrates innate and adaptive programs to eliminate disease.
-
Chimera Bioengineering
We’re unlocking the complexities of the immune system to develop highly effective, precisely targeted therapies for cancer and autoimmune diseases.
-
Compass Therapeutics
We’re unlocking the complexities of the immune system to develop highly effective, precisely targeted therapies for cancer and autoimmune diseases
-
D2G Oncology
D2G Oncology relates drugs to genotypes to transform precision cancer therapeutics.
-
Dyno Therapeutics
Dyno Therapeutics is leading a machine learning revolution to develop technologies that dramatically enhance new therapies for genetic disease.
-
Glympse Bio
We are pioneering the development of synthetic biomarkers that are bioengineered to be perfectly tunable to any disease, absolutely specific, and offer earlier measures of response.
-
ImmuneOncia Therapeutics
Our mission is to bring safe, effective, and novel immunotherapies to oncology patients world-wide.
-
Immunitas Therapeutics
Employing a single cell sequencing platform to dissect the biology of immune cells in human tumors.
-
Locus Biosciences
We are an emerging biotechnology company that develops precision antibacterial products.
-
Oncomyx
OncoMyx Therapeutics is developing oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer.
-
Rubedo Life Sciences
Our mission is to extend health-span by targeting cells in the body in an accurate and safe way.
-
Ring Therapeutics
We are developing Anellovectors™, the first potentially redosable and targetable gene therapy platform, by harnessing the human commensal virome
-
Soteria Biotherapeutics
We are developing next-generation immunotherapies with improved efficacy and safety.
-
Strand Therapeutics
Strand is increasing mRNA therapy safety and efficacy by programming the location, timing, and intensity of therapeutic protein expression inside a patient’s body using mRNA-encoded logic circuits.
-
Verve Therapeutics
Discovering and developing therapies that safely edit the genomes of adults to confer protection against coronary artery disease.
-
enGene Incorporated
enGene has developed a robust non-viral gene-therapy platform to transport DNA sequences across mucosal barriers.
-
Ribometrix
Discovering small molecule drugs that target functional 3D RNA structures to treat human diseases.
-
Asimov
Asimov strives to enable biotechnologies with global benefit by combining synthetic biology and computer science.
-
Finch
Developing and delivering innovative therapies that harness the human gut microbiome.
-
Freenome
Making cancer screening and diagnostics as accurate and accessible as possible, through a fusion of machine learning, biology and computer science.
-
Horizon
A leading gene editing company that designs and engineers genetically modified cells for clinical applications.
-
Inhibrx
Enabling fit-for-function biotherapeutics that optimally interface with the biology of each target antigen, focus immune activation, and mediate enhanced signaling.
-
Jnana Therapeutics
Jnana is pushing the frontiers of knowledge and technology to decipher the language of cellular metabolite communication and unlock SLC transporters as a therapeutic target class.
-
LogicBio Therapeutics
Harnessing the body's natural DNA repair process to provide precise, stable, and durable therapies to patients with serious genetic diseases.
-
Lumen Bioscience
Lumen Bioscience makes oral antibody therapeutics.
-
MiNA Therapeutics
Harnessing the innate mechanism of gene activation, MiNA Therapeutics' platform enables the development of new medicines that restore normal function to patients’' cells.
-
Neucyte
NeuCyte is an innovative biotechnology company focused on CNS drug discovery. NeuCyte has developed an in vitro platform for neurotoxicity assessment, disease modeling, and more.
-
Synpromics
Improving human health by enabling safer, more effective cell and gene medicines through proprietary genomics, bioinformatics and intelligent data driven design.
-
3T Biosciences
3T Biosciences is solving a major bottleneck in the field of immunotherapy – identifying novel targets that can be used to generate therapies to treat cancer in broad patient populations.
-
Aralez Bio
Aralez Bio uses engineered enzymes to make valuable products in a sustainable way.
-
Engine Biosciences
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine.
-
GO Therapeutics
GO Therapeutics is developing a range of cancer drug candidates that are exquisitely tumor specific.
-
GPCR Therapeutics
GPCR Therapeutics, Inc. is developing pharmaceuticals based on the cutting-edge knowledge of G Protein-Coupled Receptors (GPCRs).
-
Kintai Therapeutics
We leverage the body’s robust signaling networks to pioneer PEM™ compounds, a new class of precision-based orally available small molecule therapeutics to restore health and fight disease.
-
Lygos
Lygos employs cutting edge synthetic biology techniques to generate microbial catalysts to convert agricultural feedstocks into fine and commodity chemicals.
-
NovoNutrients
NovoNutrients transforms waste industrial CO2 into feed, through industrial biotech, initially for the fast-growing aquaculture sector.
-
RootPath Genomics
RootPath is a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy.
-
TCRCure Biopharma
TCRCure possesses streamlined biotechnology development including vector and cell manufacturing, which enables clinical translation intended for full-fledged immunotherapy services
-
TripleBar Bio
We see a future where biotechnology improves the sustainability of food supply production, processing, and packaging.
-
Y Biologics
Since its foundation, we have dedicated ourselves to the discovery & development of novel antibody therapeutics.
-
AgBiome
AgBiome develops innovative, cutting-edge solutions using new knowledge of the plant-associated microbiome to create novel products.
-
Bit Bio
Our mission and focus are to enable a new generation of therapies through democratising access to consistent and functional human cells.
-
EnginZyme
EnginZyme engineers cost-competitive biocatalytic solutions fast than ever before, using their universal system for enzyme immobilization.
-
Genus
Investigating the application of novel gene editing technologies towards bovine genetics.
-
MapLight Therapeutics
A transformative platform to discover and develop novel therapeutics for brain disorders.
-
Walking Fish Therapeutics
Localizing cell-based protein factories to treat serious disease.
-
Abvance
We are a science-driven biopharmaceutical start-up on a mission to deliver innovative antibody-based medicines for the treatment of immune disorders and inflammatory diseases.
-
Federation Bio
The Future of the Microbiome - Harnessing the power of defined complex microbial communities to provide a robust and lasting cure for high unmet need diseases
-
Good Therapeutics
Good Therapeutics is developing "context-dependent" protein drugs that sense biomarkers and respond with a therapeutic activity.
-
Gordian Biotechnology
Gordian is extending the reach of gene therapy to diseases of aging via a novel screening platform.
-
MacrophOx
MacrophOx is pioneering sophisticated genetic, immunological and cell biological solutions to the major challenges that currently limit cell therapy for cancer.
-
NAVAN Technologies
NAVAN Technologies, Inc. is an enabling technology company commercializing a novel non-viral delivery platform to radically accelerate genetic engineering of human primary cells.
-
PetMedix
PetMedix is using the highest quality science to make the medicines our pets need and deserve, keeping them healthier, happier, and for longer.
-
Specifica
Specifica creates antibody libraries in single chain Fv or Fab formats, in phage or yeast display platforms, and based on natural or synthetic sources.
-
Akrevia Therapeutics
Akrevia Therapeutics is focused on developing highly potent, tumor-targeted immuno-oncology therapeutics.
-
Aether Biomachines
Aether Biomachines is repurposing enzymes to reinvent previously discovered compounds and create novel compounds.
-
GeneQuine Biotherapeutics
GeneQuine Biotherapeutics GmbH develops novel therapies for osteoarthritis, a degenerative joint disease with high unmet medical need.
-
Lucira Health
We are revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing tools to empower people to become knowledgeable about their health.
-
Hexagon Bio
Mining massive amounts of genomic data from fungal genomes to identify novel drugs for diseases with unmet needs.
-
Rarecyte
RareCyte is enabling next-generation analysis of rare cells with an open and end-to-end platform that supports clinical trials worldwide.
-
Antel Biosystems (CentralStar Cooperative)
AntelBio is a leader in the development and application of innovative diagnostic solutions for the animal industry.
-
Apic Bio
Apic Bio is committed to finding cures for patients with genetic diseases and is currently developing best-in-class treatment options for rare, devastating neurological and liver diseases.
-
Axitan
Axitan has established a robust platform to engineer and grow microalgae in a cost effective and sustainable manner.
-
Biosyntia
Biosyntia is a biotech startup within synthetic biology and metabolic engineering.
-
CB Therapeutics
We Are Advancing Fermentation-based Cellular Agriculture to Produce Natural Molecules with Greater Purity, Consistency and Efficiency
-
Edi-Gene
EdiGene is translating cutting-edge genome editing technologies into novel therapeutics for genetic diseases and cancer, and into creative solutions to advance drug discovery.
-
GigaGen
GigaGen develops novel antibody therapies for patients with diseases that result from immune system dysregulation including cancer and immune deficiencies.
-
Hunterian Medicine
Hunterian Medicine is a gene editing company poised to unleash the full potential of CRISPR.
-
Hyasynth Bio
Our specialty is in producing natural molecules, derivatives, and new targets using a fast and scalable platform based on engineered microbes.
-
Immunai Inc.
ImmunAI provides a platform that combines biology with machine-learning to unravel the immune system.
-
Persona Biome
Persona Biome is dedicated to finding the health we have lost — starting with your skin.
-
Q32 Bio
Q32 Bio is a preclinical-stage company developing anti-complement therapies to treat life threatening auto-immune and inflammatory diseases.
-
Samplix
Samplix is a biotechnology company that has developed a proprietary technology for single molecule sample preparation.
-
Scenic Biotech
Scenic is pioneering genetic modifies for drug discovery to build a pipeline of breakthrough products.
-
A-Alpha Bio
We are a team of synthetic biologists and next-generation sequencing experts focused on disrupting the way that pharmaceutical companies discover, optimize, and characterize drugs.
-
Alkahest
Alkahest is targeting neurodegenerative and age-related diseases with transformative therapies derived from a deep understanding of the plasma proteome in aging and disease.
-
Amyloid Solution
Amyloid Solution seeks to overcome Alzheimer's Disease by developing innovative disease-modifying treatments that address different stages of patients during the course of disease progression.
-
Aromyx Corporation
Aromyx uses the biological receptors from the human nose to create quantitative representations of sensory data for multiple applications.
-
Azitra
Azitra Inc. is leveraging extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases.
-
Creatus Biosciences
Creatus is developing one of the most attractive mixed-sugar biorefinery platforms in the industry
-
DefiniGEN
DefiniGEN are a Cambridge UK company providing highly functional disease model human cells including hepatocytes, pancreatic beta cells and intestinal organoids.
-
Diadem Biotherapeutics
Diadem Biotherapeutics is pioneering the development of first-in-class engineered exosomes to treat chronic inflammatory and auto-immune conditions.
-
Empyrean Therapeutics
Empyrean Therapeutics is focused on developing next generation cell therapies to enable global and affordable cures for disease.
-
ExpreS2ion Biotechnologies
We are a team of highly experienced scientists specialised in developing cell lines and processes based on a non-viral Drosophila S2 cells expression system.
-
GABAeron
GABAeron focuses on engineered stem cell lines, genetic data and small-molecule drugs in hopes of developing therapeutics to preserve and maybe restore brain function in Alzheimer’s.
-
Industrial Microbes
We upgrade methane to chemicals using synthetic biology.
-
Leveragen
Leveragen is a Boston-based biotech startup company providing customized genetic modeling services.
-
Life Foundry
With synthetic biology and fully automated bio-manufacturing, we enable industrialized, on-demand, high-throughput, and flexible engineering of biological systems for practical applications.
-
Membio
Membio is on a mission to ensure the world has a safe and sufficient supply of blood.
-
Nucleo Life Sciences
Based in the San Francisco Bay Area, Nucleo Life Sciences is a boutique CMO that’s passionate about helping you take your drugs into the clinic—and the market—as quickly and effectively as humanly possible.
-
Olema Pharmaceuticals
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer.
-
OneSkin Technologies
Our mission is to be the company you can trust to keep you young while you age.
-
Phenomic AI
We’re leveraging computer vision and high-content screening to develop the next wave of therapeutic antibodies against cancer and fibrosis.
-
Redbiotec
With a proven track record in biopharmaceuticals, we aim to revolutionize advanced gene therapy to address unmet patient needs.
-
SNIPR Biome
Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
-
SyntheX
We are harnessing evolution in our synthetic biology based selection platforms to create and identify molecules that disrupt or bridge previously 'undruggable' protein-protein interactions.
-
T2 Biosystems
At T2 Biosystems, our mission is to save lives and improve healthcare by empowering clinicians to get patients on the right therapy faster.
-
Valitor
We are developing a new generation of biotechnology drugs that act precisely within a targeted diseased tissue.
-
Vectron Biosolutions AS
Vectron Biosolutions AS is your expert on developing cost-effective microbial production processes for recombinant proteins.
-
Xenocells
We are interested in changing the status quo by systematizing BIOLOGIC units and constructing modular composition rules.
-
Abalone Bio
Abalone is shifting the paradigm for antibody development, isolating drug candidates directly by their modulating effects on integral membrane proteins.
-
Anwita Bio
Anwita Biosciences is a San Francisco Bay Area startup company specializing in antibodies and fusion proteins for therapies in oncology and auto-immune disease.
-
B-MoGen Biotechnologies
We focus on complex genome engineering providing proprietary, cutting edge gene delivery and editing tools to enable faster research and cost effective therapies.
-
Bio-Meme
Biomeme's platform transforms your smartphone into a mobile lab for advanced DNA diagnostics and real-time disease surveillance.
-
BioPlx Microbiomics
BioPlx is an advanced microbiomics company developing non-antibiotic methods for the control of infectious disease, including multiple-drug resistant "super-bugs".
-
Quintara Bio
Quintara Biosciences specializes in providing high quality DNA sequencing and genomic services for life science research communities around the globe.
-
Seer Biosciences
Seer is extracting deep molecular insights from the proteome to enable early detection of cancer and neurological diseases, drive earlier treatment, and improve patient outcomes.
-
Zymochem
Our mission is to develop microbes & bioprocesses that enable profitable and eco-friendly production of chemicals from renewable sources such as sugars.
-
Algen Biotechnologies
Decoding functional gene networks for therapeutics discovery.
-
Artisan Bio
The Artisan team is passionate about crafting customized cell engineering solutions to solve the most challenging problems in human health applications.
-
Asher Biotherapeutics
We build better immunotherapies.
-
Function Oncology
Making precision oncology a reality for cancer patients.
-
ImmunityBio
Leading late-stage immunotherapy company harnessing immunogenic cell death.
-
Lytica Therapeutics
Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.
-
Aanika Biosciences
Aanika Biosciences, Inc. provides food security services for large food and agricultural companies. We use synthetic biology to ensure the integrity of supply chains and reduce potential losses.
-
Bluestar Genomics
Bluestar Genomics is an exciting new startup life science company that is reinventing non-invasive molecular diagnostic testing using next generation epigenomic technologies.
-
ExoPolymer
ExoPolymer designs and produces next-generation, high-performance hydrocolloid ingredients for companies focused on healthcare, food, and personal care solutions.
-
Exosome Diagnostics
Exosome Diagnostics, Inc. is commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases.
-
First Light Diagnostics
First Light Diagnostics develops innovative diagnostic tests that enable rapid and accurate detection of pathogens that can cause life-threatening infections.
-
Gensun Biopharma
Gensun Biopharma Inc. is focusing on the discovery and development of proprietary novel biological therapeutics for the treatment of cancer and other selected disease areas.
-
InVivo Biosystems
Our mission is to accelerate deep in-vivo insights into human biology and enable researchers to develop and deliver solutions that improve human health.
-
Iris Medicine
Developing medicines that target the root of neurodegeneration.
-
Kisbee Therapeutics
Apolipoprotein-based drug discovery
-
Neochromosome, Inc.
Our disruptive chromosome synthesis and engineering technologies are changing the world of synthetic biology.
-
Neurognos
Our mission is to make Alzheimer’s and other neurodegenerative disease detection accessible to people everywhere in the world even before the first symptoms arise.
-
Octant
We are applying next-generation DNA sequencing, gene synthesis, and gene editing to revolutionize drug discovery in a quest for safer, more effective, and cheaper drugs
-
Revel Pharmaceuticals
Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associated molecule damage.
-
Sound Biologics
Sound Biologics creates innovative technology to better serve patients through the development of treatments for cancer.
-
TurtleTree Labs
TurtleTree Labs is recreating the full composition, functionality and taste of milk using the latest cutting edge innovation in biotech.
-
Tegmine Therapeutics
We believe that the high cost of healthcare can be addressed by mixing biology, technology, and machine learning.
-
Boost Biomes
Boost Biomes is using the powerful social networks among microbes to provide novel, sustainable solutions to feed and heal people everywhere.
